Abstract
Objective To explore the clinical effect of hemodialysis without heparin in hemodialysis patients with cerebral hemorrhage. Methods A total of 48 hemodialysis patients with cerebral hemorrhage who were admitted to our hospital from March 2016 to March 2018 were selected and divided into a control group (n=24) and an observation group (n=24), and low-dose low-molecular-weight heparin and no heparin dialysis were given. Serum cTnT and UA results, dialysis costs, survival rates and complications were compared between the two groups. Results After hemodialysis, serum cTnT and UA levels in the observation group were significantly lower than those in the control group (P 0.05). Complications and survival of the observation group was significantly better than the control group (P<0.05). Conclusion There is no significant difference between the daily average dialysis cost and the low-dose low-molecular-weight heparin dialysis treatment for hemodialysis patients with intracerebral hemorrhage, and heparin-free dialysis is safe and effective. Key words: Heparin-free dialysis; Low molecular weight heparin; Hemodialysis; Cerebral hemorrhage
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
